On Nov. 5, 2024, a World Health Organization (WHO) study published in eBioMedicine named 17 pathogens that regularly…
On Oct. 20, 2024, the World Health Organization (WHO) announced it had certified Egypt as malaria-free, marking a…
On Sept. 19, 2024, Oxitec announced it had launched Sparks™, a new commercial platform to accelerate the global…
On Jan. 12, 2024, the World Health Organization (WHO) announced it had certified Cabo Verde as a malaria-free…
On Dec. 21, 2023, the World Health Organization (WHO) announced that it had prequalified the R21/Matrix-M malaria vaccine…
On Oct. 2, 2023, the World Health Organization (WHO) announced it had recommended a new vaccine, R21/Matrix-M, developed…
On Aug. 24, 2023, NIAID reported that emerging resistance to common malaria treatments in Uganda could be connected…
On Aug. 18, 2023, the Maryland Department of Health has confirmed and reported a positive case of locally…
On Jun. 26, 2023, the Centers for Disease Control and Prevention (CDC) announced they were collaborating with U.S….
On Jun. 21, 2023, the World Health Organization announced that it had certified Belize as malaria-free, following the…
On Mar. 29, 2023, the World Health Organization (WHO) announced that it had certified Azerbaijan and Tajikistan for…
On Oct. 31, 2022, the National Institutes of Health announced that a clinical trial had found that one…
On Sept. 29, 2022, the World Health Organization announced that it had identified the spread of Anopheles stephensi…
On Sept. 20, 2022, the University of California, Davis announced that the amphibian decline in Latin America in…
On Sept. 8, 2022, researchers from the University of Oxford and their partners reported findings from their Phase…
On Aug. 16, 2022, UNICEF announced that it had awarded a contract for the first ever supply of…
On Mar. 4, 2022, the WHO announced it had published an updated position paper on the RTS,S/AS01 (RTS,S)…
On Dec. 3, 2021, Gavi, the Vaccine Alliance, approved a new malaria vaccination programme to support the introduction,…
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
On Oct. 6, 2021, the World Health Organization recommended widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among…
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
On Aug. 11, 2021, the National Institutes of Health (NIH) announced that one dose of a new monoclonal…
On Jun. 30, 2021, the National Institutes of Health announced that two U.S. Phase 1 clinical trials of…
On Jun. 30, 2021, following a 70-year effort, China was awarded a malaria-free certification from the World Health…
On Apr. 20, 2021, the World Health Organization (WHO) announced that two years on from the launch of…
On Oct. 14, 2020, recognizing the urgent need for new tools to combat vector-borne diseases (VBDs), and in…
On Jul. 30, 2020, researchers at the National Institutes of Health and other institutions announced they had discovered…
On May 26, 2020, the FDA provided approval to Amivas for its artesunate for injection to treat severe…
On May 26, 2020, the FDA approved Amivas’ artesunate for injection to treat severe malaria in adult and…
On May 18, 2020, with $9 million from the COVID-19 Therapeutics Accelerator, an international group of physicians and…